ECSP961635A - CONTROLLED RELEASE OF STEROIDS FROM SUGAR COATING - Google Patents

CONTROLLED RELEASE OF STEROIDS FROM SUGAR COATING

Info

Publication number
ECSP961635A
ECSP961635A ECSP961635A ECSP961635A EC SP961635 A ECSP961635 A EC SP961635A EC SP961635 A ECSP961635 A EC SP961635A EC SP961635 A ECSP961635 A EC SP961635A
Authority
EC
Ecuador
Prior art keywords
steroids
controlled release
sugar coating
sugar
steroid
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Barcomb Joseph Reginald
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP961635 priority Critical patent/ECSP961635A/en
Publication of ECSP961635A publication Critical patent/ECSP961635A/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a una composición con recubrimiento de azúcar para la aplicación a una tableta medical comprimida, compuesta de azúcar una dosificación de un esteroide hormonal y un porcentaje de desprendimiento de esteroide que controle la cantidad de celulosa microcristalina.The present invention relates to a sugar-coated composition for application to a compressed medical tablet, composed of sugar, a dosage of a hormonal steroid and a percentage of steroid release that controls the amount of microcrystalline cellulose.

ECSP961635 1996-01-11 1996-01-11 CONTROLLED RELEASE OF STEROIDS FROM SUGAR COATING ECSP961635A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP961635 ECSP961635A (en) 1996-01-11 1996-01-11 CONTROLLED RELEASE OF STEROIDS FROM SUGAR COATING

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP961635 ECSP961635A (en) 1996-01-11 1996-01-11 CONTROLLED RELEASE OF STEROIDS FROM SUGAR COATING

Publications (1)

Publication Number Publication Date
ECSP961635A true ECSP961635A (en) 1997-06-27

Family

ID=42042369

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP961635 ECSP961635A (en) 1996-01-11 1996-01-11 CONTROLLED RELEASE OF STEROIDS FROM SUGAR COATING

Country Status (1)

Country Link
EC (1) ECSP961635A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11793812B2 (en) 2016-09-30 2023-10-24 Sumitomo Pharma Switzerland Gmbh Methods of treating endometriosis
US12551447B2 (en) 2020-05-29 2026-02-17 Sumitomo Pharma Co., Ltd. Combination solid oral dosage forms of gonadotropin-releasing hormone antagonists

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11793812B2 (en) 2016-09-30 2023-10-24 Sumitomo Pharma Switzerland Gmbh Methods of treating endometriosis
US11957684B2 (en) 2016-09-30 2024-04-16 Sumitomo Pharma Switzerland Gmbh Treatment of heavy menstrual bleeding associated with uterine fibroids
US12551447B2 (en) 2020-05-29 2026-02-17 Sumitomo Pharma Co., Ltd. Combination solid oral dosage forms of gonadotropin-releasing hormone antagonists

Similar Documents

Publication Publication Date Title
AR002019A1 (en) A SUGAR COATING COMPOSITION FOR APPLICATION TO A COMPRESSED MEDICINAL TABLET AND A COMPRESSED TABLET.
ES2179165T3 (en) CONTROLLED RELEASE OF STEROIDS FROM SUGAR COATINGS.
EP1319404A3 (en) Composition for treating and/or prophylaxis of tumors of the breast
ES2174629T3 (en) 14,15-CYCLOPROPAN-STEROIDS OF THE 19-NOR-ANDROSTAN SERIES, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL FORMULATIONS CONTAINING THESE COMPOUNDS.
DK1089722T3 (en) Transdermal matrix type patch for steroid hormones
WO1998027929A3 (en) Therapeutic gestagens for the treatment of premenstrual dysphoric disorder
NO964089L (en) Pharmaceutical combination preparation for hormonal contraception
BR0014569A (en) Pattern-coated adhesive article, method for forming an adhesive article and method for facilitating wound healing
NZ333822A (en) Tramadol multiple unit formulations comprising individual pellets of trmadol coated with one or more membrane layers for controlling release
NO976067D0 (en) Pharmaceutical combination preparation, kits and method of hormonal contraception
ES2175451T3 (en) PROCEDURE FOR THE PREPARATION OF DROSPIRENONE AND ITS INTERMEDIATE PRODUCTS.
ES2172592T3 (en) PROGESTERONE ANTAGONIST AGENT AND GESTAGEN AGENT FOR THE TREATMENT OF ENDOMETRIOSIS AND UTERINE LIOMIOMA.
PL2131847T3 (en) Drug comprising at least one gestagen
DE122007000011I1 (en) Solid dosage forms containing clathrates of the steroidal sex hormone ethinyl estradiol
BG104397A (en) Extended release formulation
DK0871453T3 (en) Pharmaceutical combination hormone contraceptive
AU6367496A (en) New hormonal medicaments and their use for the correction of oestrogenic deficiencies
WO2000037109A3 (en) Clathrates of dehydroepiandrosterone and corresponding pharmaceutical compositions
EP1090639A3 (en) Pharmaceutical composition containing a progestational corticoid and a selective estrogen receptor modulator
GR3025872T3 (en) Orally active derivatives of 1,3,5(10)-estratriene
WO2002074315A8 (en) Pharmaceutical combined preparations containing aromatase inhibitors and substances having an estrogen effect in addition to the use thereof for producing a medicament for estrogen-replacement-therapy
DOP2023000029A (en) NEW COMPOSITION OF MODIFIED RELEASE ORAL CONTRACEPTIVE
BRPI0511864A (en) use of a combination of ethinyl estradiol and chormadinone acetate for the preparation of a medicament
AR070023A1 (en) USE OF GESTAGENS IN COMBINATION WITH (6S) -5-METHYL-TETRAHYDROPHOLATE FOR THERAPY OF ENDOMETRIOSIS WITH SIMULTANEOUS REDUCTION OF THERAPEUTIC COLLATERAL EFFECTS AND REDUCTION OF THE RISK OF CONGENITAL MALFORMATIONS AT THE BEGINNING OF BEGIN
ECSP971998A (en) CONTROLLED RELEASE OF STEROIDS FROM SUGAR COATING